top of page

Inflammation

Cannabinoid Delivery Systems for Pain and Inflammation Treatment
​
Cannabidiol Reduces Intestinal Inflammation throughthe Control of Neuroimmune Axis
​
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
​
The endocannabinoid system: an emerging key player in inflammation
​
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice
​
Cannabinoids, endocannabinoids, and related analogs in inflammation
​
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor
​
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
​
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
​
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
​
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
​
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
​
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
​
Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death
​
Cannabinoids in clinical practice
​
CBD Absorption Rates for Pain and Inflammation Treatment
bottom of page